Irvine Scientific Acquires BioCare Europe
News Jan 08, 2016
Based in Rome, Italy, BioCare is a leading distributor of in vitro fertilization (IVF) media, medical devices, and equipment.
Irvine Scientific provides the IVF market with cGMP cell culture media which is unrivalled in performance and quality. Supporting IVF hospitals and clinics worldwide, Irvine Scientific has been building a sales presence in Europe over the last several years, focused mainly in the UK, France, and Germany. BioCare is a leading distributor of a wide variety of IVF products to the European market and has built a strong sales network in Europe, focused mainly in Italy, France, Greece, Portugal and Spain.
The IVF market in Europe is the largest worldwide and is expected to grow stably. By leveraging the capabilities of BioCare and maximizing the synergy between the two companies Irvine Scientific will expand its presence in the European IVF market to take advantage of that growth.
“We are delighted to announce the acquisition of BioCare.” said Yuichi Nagano, President and CEO, Irvine Scientific. “With its well established network across the continent BioCare provides the connections and operations to enable us to better serve the European IVF market.”
New Drug to Treat Herpes Simplex Virus Infection?News
Researchers have now identified a small drug molecule that can clear the HSV-1 infection in the cells of the cornea -- the clear outer layer of the eyeball -- and works completely differently than the currently-available drugs, making it a promising potential option for patients who have developed resistance.READ MORE
From Human Biopsy to Complex Gut Physiology on a ChipNews
Organ Chip technology using donor-derived human intestinal cells offers advantages over organoids and creates new opportunities for personalized medicine.READ MORE
Liver-on-a-chip Used to Test Hepatitis B Virus InfectionNews
Scientists at Imperial College London have become the first in the world to test how pathogens interact with artificial human organs.READ MORE